JESSICA DE OCHOA GARZA: Open Payments
NPI 1235880717 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$572 in 15 payments from 8 companies in 2025. Trend: 2023 $4,860 · 2024 $592 · 2025 $572
Food & beverage: $572
| Company | Payments | Amount |
|---|---|---|
| Organogenesis Inc. | 2 | $155 |
| Optinose US, Inc. | 5 | $110 |
| Smith+Nephew, Inc. | 1 | $91 |
| Solventum Corporation | 2 | $74 |
| Medtronic, Inc. | 2 | $72 |
| Phadia US Inc. | 1 | $36 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
Products named: PURAPLY WOUND MATRIX, Xhance, PROPEL, V.A.C. VERAFLO CLEANSE CHOICE, ImmunoCAP, V.A.C. VERAFLO, NUVENT, AFFINITY.
Industry payments across TX — which companies pay providers there.
